The U.S. Generic Drugs Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Generic Drugs industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Generic Drugs market analysis is provided for the U.S. markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on U.S. major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Generic Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 161 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
Chapter One Industry Overview
1.1 Definition and Specifications of Generic Drugs
1.2 Classification of Generic Drugs
1.3 Applications of Generic Drugs
1.4 Industry Chain Structure of Generic Drugs
1.5 Industry Overview of Generic Drugs
1.6 Industry Policy Analysis of Generic Drugs
1.7 Industry News Analysis of Generic Drugs
Chapter Two Manufacturing Cost Structure Analysis of Generic Drugs
2.1 Bill of Materials (BOM) of Generic Drugs
2.2 BOM Price Analysis of Generic Drugs
2.3 Labor Cost Analysis of Generic Drugs
2.4 Depreciation Cost Analysis of Generic Drugs
2.5 Manufacturing Cost Structure Analysis of Generic Drugs
2.6 Manufacturing Process Analysis of Generic Drugs
Chapter Three Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of U.S. Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of U.S. Key Generic Drugs Manufacturers in 2014
3.3 R&D Status and Technology Source of U.S. Generic Drugs Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of U.S. Generic Drugs Key Manufacturers in 2014
Chapter Four Production Analysis of Generic Drugs by Regions, Technology, and Applications
4.1 U.S. Production of Generic Drugs by Regions (Key Provinces) 2010-2015
4.2 U.S. Production of Generic Drugs by Product Types 2010-2015
4.3 U.S. Sales of Generic Drugs by Applications 2010-2015
4.4 Price Analysis of U.S. Generic Drugs Key Manufacturers in 2015
4.5 U.S. Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Generic Drugs 2010-2015
Chapter Five Sales and Revenue Analysis of Generic Drugs by Regions
5.1 U.S. Sales of Generic Drugs by Regions 2010-2015
5.2 U.S. Revenue of Generic Drugs by Regions 2010-2015
5.3 U.S. Price Analysis of Generic Drugs Sales by Regions 2010-2015
5.4 U.S. Price, Cost and Gross of Generic Drugs 2010-2015
Chapter Six Analysis of Generic Drugs Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity Production Sales Revenue of Generic Drugs 2010-2015
6.2 Production Sales Market Share Analysis of Generic Drugs 2014-2015
6.3 Import, Export and Consumption of Generic Drugs 2010-2015
6.4 Supply, Consumption and Shortage of Generic Drugs 2010-2015
6.5 Import, Export and Consumption of Generic Drugs 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Generic Drugs 2010-2015
Chapter Seven Analysis of Generic Drugs Industry Key Manufacturers
7.1 Amneal Pharmaceuticals
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Amneal Pharmaceuticals SWOT Analysis
7.2 Actavis
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Actavis SWOT Analysis
7.3 Dr. Reddy's Laboratories
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Dr. Reddy's Laboratories SWOT Analysis
7.4 Endo International
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Endo International SWOT Analysis
7.5 Sandoz
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Sandoz SWOT Analysis
7.6 Pfizer
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Pfizer SWOT Analysis
7.7 Lupin
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Lupin SWOT Analysis
7.8 Mylan
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Mylan SWOT Analysis
7.9 Zydus Pharmaceuticals
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Zydus Pharmaceuticals SWOT Analysis
7.10 Teva Pharmaceuticals USA
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Teva Pharmaceuticals USA SWOT Analysis
Chapter Eight Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Generic Drugs Product Types
8.5 Market Share Analysis of Different Generic Drugs Price Levels
8.6 Gross Margin Analysis of Different Generic Drugs Applications
Chapter Nine Marketing Trader or Distributor Analysis of Generic Drugs
9.1 Marketing Channels Status of Generic Drugs
9.2 Traders or Distributors of Generic Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Generic Drugs
9.4 U.S. Import, Export and Trade Analysis of Generic Drugs
Chapter Ten Development Trend of Generic Drugs Industry 2015-2020
10.1 Capacity and Production Overview of Generic Drugs 2015-2020
10.2 Production Market Share by Product Types of Generic Drugs 2015-2020
10.3 Sales and Sales Revenue Overview of Generic Drugs 2015-2020
10.4 U.S. Sales of Generic Drugs by Applications 2015-2020
10.5 Import, Export and Consumption of Generic Drugs 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Generic Drugs 2015-2020
Chapter Eleven Industry Chain Suppliers of Generic Drugs with Contact Information
11.1 Major Raw Materials Suppliers of Generic Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Generic Drugs with Contact Information
11.3 Major Players of Generic Drugs with Contact Information
11.4 Key Consumers of Generic Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Generic Drugs
Chapter Twelve New Project Investment Feasibility Analysis of Generic Drugs
12.1 New Project SWOT Analysis of Generic Drugs
12.2 New Project Investment Feasibility Analysis of Generic Drugs
Chapter Thirteen Conclusion of the U.S. Generic Drugs Industry 2015 Market Research Report
List of Tables and Figures
Figure Picture of Generic Drugs
Table Product Specifications of Generic Drugs
Table Classification of Generic Drugs
Figure U.S. Sales Market Share of Generic Drugs by Product Types in 2014
Table Applications of Generic Drugs
Figure U.S. Sales Market Share of Generic Drugs by Applications in 2014
Figure Industry Chain Structure of Generic Drugs
Table U.S. Industry Overview of Generic Drugs
Table Industry Policy of Generic Drugs
Table Industry News List of Generic Drugs
Table Bill of Materials (BOM) of Generic Drugs
Table Bill of Materials (BOM) Price of Generic Drugs
Table Labor Cost of Generic Drugs
Table Depreciation Cost of Generic Drugs
Table Manufacturing Cost Structure Analysis of Generic Drugs in 2014
Figure Manufacturing Process Analysis of Generic Drugs
Table Capacity (K Person-portion) and Commercial Production Date of U.S. Generic Drugs Key Manufacturers in 2014
Table Manufacturing Plants Distribution of U.S. Key Generic Drugs Manufacturers in 2014
Table R&D Status and Technology Source of U.S. Generic Drugs Key Manufacturers in 2014
Table Raw Materials Sources Analysis of U.S. and U.S. Generic Drugs Key Manufacturers in 2014
Table U.S. Production of Generic Drugs by Regions 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Generic Drugs by Regions 2010-2015 (%)
Figure U.S. Production Market Share of Generic Drugs by Regions in 2014
Figure U.S. Production Market Share of Generic Drugs by Regions in 2015
Table U.S. Production of Generic Drugs by Product Types in 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Generic Drugs by Product Types in 2010-2015 (%)
Figure U.S. Production Market Share of Generic Drugs by Technology in 2014
Figure U.S. Production Market Share of Generic Drugs by Technology in 2015
Figure U.S. Sales of Generic Drugs by Applications 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Generic Drugs by Applications 2010-2015 (%)
Figure U.S. Production Market Share of Generic Drugs by Applications in 2014
Figure U.S. Production Market Share of Generic Drugs by Applications in 2015
Table Price Comparison of U.S. Generic Drugs Key Manufacturers in 2015 (USD/Person-portion)
Table U.S. Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Generic Drugs 2010-2015
Table U.S. Sales of Generic Drugs by Regions 2010-2015 (K Person-portion)
Table U.S. Sales Market Share of Generic Drugs by Regions 2010-2015 (%)
Figure U.S. Sales of Generic Drugs by Regions in 2014 (K Person-portion)
Figure U.S. Sales of Generic Drugs by Regions in 2015 (K Person-portion)
Table U.S. Revenue of Generic Drugs by Regions 2010-2015 (M USD)
Table U.S. Revenue of Generic Drugs by Regions 2010-2015 (%)
Figure U.S. Revenue of Generic Drugs by Regions in 2014 (%)
Figure U.S. Revenue of Generic Drugs by Regions in 2015 (%)
Table Sales Price of Generic Drugs by Regions 2010-2015 (USD/Person-portion)
Table U.S. Price Analysis of Generic Drugs 2010-2015 (USD/Person-portion)
Table U.S. Cost Analysis of Generic Drugs 2010-2015 (USD/Person-portion)
Table U.S. Gross Analysis of Generic Drugs 2010-2015
Table U.S. and Major Manufacturers Capacity of Generic Drugs 2010-2015 (K Person-portion)
Table U.S. Capacity Market Share of Major Generic Drugs Manufacturers 2010-2015 (%)
Table U.S. and Major Manufacturers Production of Generic Drugs 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Major Generic Drugs Manufacturers 2010-2015 (%)
Table U.S. and Major Manufacturers Sales of Generic Drugs 2010-2015 (K Person-portion)
Table U.S. Sales Market Share of Major Generic Drugs Manufacturers 2010-2015 (%)
Table U.S. and Major Manufacturers Sales Revenue of Generic Drugs 2010-2015 (M USD)
Table U.S. Sales Revenue Market Share of Major Generic Drugs Manufacturers 2010-2015 (%)
Figure U.S. Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Generic Drugs 2010-2015
Figure U.S. Capacity Utilization Rate of Generic Drugs 2010-2015
Figure U.S. Sales Revenue (M USD) and Growth Rate of Generic Drugs 2010-2015
Figure U.S. Production Market Share of Major Generic Drugs Manufacturers in 2014
Figure U.S. Production Market Share of Major Generic Drugs Manufacturers in 2015
Figure U.S. Sales Market Share of Major Generic Drugs Manufacturers in 2014
Figure U.S. Sales Market Share of Major Generic Drugs Manufacturers in 2015
Table U.S. Import, Export and Consumption of Generic Drugs 2010-2015 (K Person-portion)
Table U.S. and Major Manufacturers Local Sales Export Import of Generic Drugs 2010-2015 (K Person-portion)
Table U.S. Supply, Consumption and Shortage of Generic Drugs 2010-2015 (K Person-portion)
Table U.S. Import, Export and Consumption of Generic Drugs 2010-2015 (K Person-portion)
Table Price of U.S. Generic Drugs Major Manufacturers 2010-2015 (USD/Person-portion)
Table Gross Margin of U.S. Generic Drugs Major Manufacturers 2010-2015
Table U.S. and Major Manufacturers Revenue of Generic Drugs 2010-2015 (M USD)
Table U.S. Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Generic Drugs 2010-2015
Table Amneal Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Amneal Pharmaceuticals
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Amneal Pharmaceuticals 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Amneal Pharmaceuticals 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Amneal Pharmaceuticals 2010-2015
Table Amneal Pharmaceuticals Generic Drugs SWOT Analysis
Table Actavis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Actavis
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Actavis 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Actavis 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Actavis 2010-2015
Table Actavis Generic Drugs SWOT Analysis
Table Dr. Reddy's Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Dr. Reddy's Laboratories
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Dr. Reddy's Laboratories 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Dr. Reddy's Laboratories 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Dr. Reddy's Laboratories 2010-2015
Table Dr. Reddy's Laboratories Generic Drugs SWOT Analysis
Table Endo International Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Endo International
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Endo International 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Endo International 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Endo International 2010-2015
Table Endo International Generic Drugs SWOT Analysis
Table Sandoz Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Sandoz
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Sandoz 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Sandoz 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Sandoz 2010-2015
Table Sandoz Generic Drugs SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Pfizer
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Pfizer 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Pfizer 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Pfizer 2010-2015
Table Pfizer Generic Drugs SWOT Analysis
Table Lupin Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Lupin
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Lupin 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Lupin 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Lupin 2010-2015
Table Lupin Generic Drugs SWOT Analysis
Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Mylan
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Mylan 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Mylan 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Mylan 2010-2015
Table Mylan Generic Drugs SWOT Analysis
Table Zydus Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Zydus Pharmaceuticals
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Zydus Pharmaceuticals 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Zydus Pharmaceuticals 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Zydus Pharmaceuticals 2010-2015
Table Zydus Pharmaceuticals Generic Drugs SWOT Analysis
Table Teva Pharmaceuticals USA Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Teva Pharmaceuticals USA
Table Generic Drugs Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Teva Pharmaceuticals USA 2010-2015
Figure Generic Drugs Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Teva Pharmaceuticals USA 2010-2015
Figure Generic Drugs Production (K Person-portion) and U.S. Market Share of Teva Pharmaceuticals USA 2010-2015
Table Teva Pharmaceuticals USA Generic Drugs SWOT Analysis
Table Generic Drugs Price by Regions 2010-2015
Table Generic Drugs Price by Product Types 2010-2015
Table Generic Drugs Price by Company 2010-2015
Table Generic Drugs Gross Margin by Company 2010-2015
Table Price Comparison of Generic Drugs by Regions 2010-2015 (USD/Person-portion)
Table Price of Different Generic Drugs Product Types (USD/Person-portion)
Table Market Share of Different Generic Drugs Price Level
Table Gross Margin of Different Generic Drugs Applications
Table Marketing Channels Status of Generic Drugs
Table Traders or Distributors of Generic Drugs with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Generic Drugs (USD/Person-portion)
Table U.S. Import, Export, and Trade of Generic Drugs (K Person-portion)
Figure U.S. Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Generic Drugs 2015-2020
Figure U.S. Capacity Utilization Rate of Generic Drugs 2015-2020
Table U.S. Generic Drugs Production by Product Types 2010-2015 (K Person-portion)
Table U.S. Generic Drugs Production Market Share by Product Types 2010-2015 (%)
Figure U.S. Production Market Share of Generic Drugs by Technology in 2020
Figure U.S. Sales (K Person-portion) and Growth Rate of Generic Drugs 2015-2020
Figure U.S. Sales Revenue (Million USD) and Growth Rate of Generic Drugs 2015-2020
Figure U.S. Sales of Generic Drugs by Applications 2015-2020 (K Person-portion)
Table U.S. Production Market Share of Generic Drugs by Applications 2015-2020 (%)
Figure U.S. Production Market Share of Generic Drugs by Applications in 2020
Table U.S. Production, Import, Export and Consumption of Generic Drugs 2015-2020 (K Person-portion)
Table U.S. Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Generic Drugs 2015-2020
Table Major Raw Materials Suppliers of Generic Drugs with Contact Information
Table Manufacturing Equipment Suppliers of Generic Drugs with Contact Information
Table Major Players of Generic Drugs with Contact Information
Table Key Consumers of Generic Drugs with Contact Information
Table Supply Chain Relationship Analysis of Generic Drugs
Table New Project SWOT Analysis of Generic Drugs
Table New Project Investment Feasibility Analysis of Generic Drugs
Table Part of Interviewees Record List
